Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Oncology Taking On Drug Distribution Role

Executive Summary

Cancer services company US Oncology is building its own drug distribution capacity to serve medical practices in its oncology network

You may also be interested in...



Part B Competitive Acquisition Plan Needs Significant Changes, Attorney Says

The Centers for Medicare & Medicaid Services' proposal for competitive acquisition of Part B-covered drugs requires "significant changes" to be effective, attorney Carolyn McElroy told an American Conference Institute/Pharmaceutical Care Management Association conference in Washington, D.C. April 18

U.S. Oncology To Go Private Ahead Of Medicare Part B Changes In 2005

U.S. Oncology plans to go private ahead of the 2005 reimbursement changes for chemotherapy drugs under the Medicare prescription drug law

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

Topics

UsernamePublicRestriction

Register

PS063835

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel